Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Reiners

Showing results (81-90 of 133) with videos related to

Pageof 14
Sort By:
Annals of Surgery|March 23, 2006
Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of BelarusYuri E Demidchik, Eugene P Demidchik, Christoph Reiners, et al.
Thyroid : Official Journal of the American Thyroid Association|April 8, 2004
Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995Jamshid Farahati, Markus Geling, Uwe Mäder, et al.
Nuclear Medicine Review. Central & Eastern Europe|September 1, 2012
Recombinant human thyrotropin to help confirm lack of evidence of radiation-induced differentiated thyroid cancer in young women seeking pregnancyValentina Drozd, Tatjana Leonova, Tatjana Mitjukova, et al.
Clinical Endocrinology|October 25, 2011
Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapyFrederik A Verburg, Johannes W A Smit, Inge Grelle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 12, 2003
Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinomaMarkus Luster, Steven I Sherman, Monica C Skarulis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 2012
Recombinant human TSH versus thyroid hormone withdrawalFrederik A Verburg, Markus Dietlein, Lutz Freudenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomasSamuel Samnick, Bernd F Romeike, Thomas Lehmann, et al.
The Journal of Clinical Endocrinology and Metabolism|May 27, 2011
I-131 activities as high as safely administrable (AHASA) for the treatment of children and adolescents with advanced differentiated thyroid cancerFrederik A Verburg, Johannes Biko, Stefanie Diessl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 25, 2009
Dosimetry-guided high-activity (131)I therapy in patients with advanced differentiated thyroid carcinoma: initial experienceFrederik A Verburg, Heribert Hänscheid, Johannes Biko, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 16, 2009
[Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology]Anja Eckstein, Klaus Mann, George J Kahaly, et al.
Pageof 14

Showing results (81-90 of 133) with videos related to

Sort By:
Pageof 14
Annals of Surgery|March 23, 2006
Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of BelarusYuri E Demidchik, Eugene P Demidchik, Christoph Reiners, et al.
Thyroid : Official Journal of the American Thyroid Association|April 8, 2004
Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995Jamshid Farahati, Markus Geling, Uwe Mäder, et al.
Nuclear Medicine Review. Central & Eastern Europe|September 1, 2012
Recombinant human thyrotropin to help confirm lack of evidence of radiation-induced differentiated thyroid cancer in young women seeking pregnancyValentina Drozd, Tatjana Leonova, Tatjana Mitjukova, et al.
Clinical Endocrinology|October 25, 2011
Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapyFrederik A Verburg, Johannes W A Smit, Inge Grelle, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 12, 2003
Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinomaMarkus Luster, Steven I Sherman, Monica C Skarulis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 2012
Recombinant human TSH versus thyroid hormone withdrawalFrederik A Verburg, Markus Dietlein, Lutz Freudenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomasSamuel Samnick, Bernd F Romeike, Thomas Lehmann, et al.
The Journal of Clinical Endocrinology and Metabolism|May 27, 2011
I-131 activities as high as safely administrable (AHASA) for the treatment of children and adolescents with advanced differentiated thyroid cancerFrederik A Verburg, Johannes Biko, Stefanie Diessl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 25, 2009
Dosimetry-guided high-activity (131)I therapy in patients with advanced differentiated thyroid carcinoma: initial experienceFrederik A Verburg, Heribert Hänscheid, Johannes Biko, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 16, 2009
[Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology]Anja Eckstein, Klaus Mann, George J Kahaly, et al.
Pageof 14